Biological processes, consisting of ones needed for life and those that lead to cancer, occur at the nanoscale. Nanotechnology provides researchers with the possibility to study and control macromolecules in real time and throughout the earliest phases of cancer development. Nanotechnology additionally has the prospective to generate completely novel and highly efficient therapeutic agents. Released in 2004, the NCI Alliance for Nanotechnology in Cancer program is a comprehensive, organized effort, incorporating the public and personal sector to merge multidisciplinary research in nanotechnology to progress the fight versus cancer. An efficient, collaborative system of data sharing is vital in the translation of nanotechnology research into readily sensible therapies and diagnostics to deal with patients.
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions
** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.
Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.